Christopher Anderson, a distinguished IP Expert consistently recognized by Lexology (formerly Who’s Who Legal), brings over two decades of experience as a testifying and consulting financial expert. He provides critical financial analyses and strategic insights in intellectual property, valuation, and complex litigation matters and frequently serves as a testifying and consulting financial expert in high stakes litigation.

Chris advises clients and counsel on intellectual property matters, focusing on economic damages disputes, licensing, and related issues. He frequently serves as a testifying expert witness, quantifying economic damages in cases involving patent, trademark, and copyright infringement, and trade secret misappropriation. His expertise also extends to assessing financial harm stemming from breach of contract, tortious interference, and breach of fiduciary duty. Outside of litigation, Chris collaborates with clients on IP-centric matters such as licensing, valuation, and tax, providing comprehensive economic analysis and communicating key findings to stakeholders.

Chris has been qualified and designated as an expert in a variety of judicial and alternative dispute resolution forums. This encompasses federal courts across several districts (e.g., California, Texas, Georgia, Massachusetts, Pennsylvania, Delaware), state courts (California, Texas), Canadian Federal Court, and arbitration proceedings.

Over the course of his career, Chris has worked with clients across a range of industries including medical devices, pharmaceuticals, genomic sequencing, oil and gas, semiconductors, telecommunication and computer hardware and software.

Chris is a frequent speaker on intellectual property, commercial damages and valuation-related topics at events hosted by the Licensing Executives Society, the Texas Society of Certified Public Accountants, Institute of Management Accountants, and ABA, among others. He has also served as a guest lecturer on IP valuation for the Naveen Jindal School of Management graduate program in entrepreneurship and for an undergraduate course in the Department of Economics at the University of Texas at Austin.

Before joining StoneTurn, Chris developed eight years of experience in the healthcare sector, combining financial analysis with clinical research. He supported a top-ranked academic medical center by analyzing the financial and operational feasibility of integrating new medical technologies. His background also includes managing Phase I and II clinical trials as a clinical monitor and study coordinator for two contract research organizations.

Chris holds the Certified Licensing Professional designation from the Licensing Executives Society, the Certified Management Accountant and Certified Financial Manager credentials from the Institute of Management Accountants, and the Certified Valuation Analyst credential from the National Association of Certified Valuators and Analysts.